QT
CABA icon

Quantbot Technologies’s Cabaletta Bio CABA Stock Holding History

Quantbot Technologies’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19
Closed -$43 – 1498
2024
Q4 		$43 Buy
+19
New +$67 ﹤0.01% 1424
2024
Q2 		– Sell
-300
Closed -$5.12K – 1476
2024
Q1 		$5.12K Sell
300
-1,200
-80% -$25.8K ﹤0.01% 1484
2023
Q4 		$34K Buy
+1,500
New +$25.2K ﹤0.01% 1381

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's CABA Position: Q1 2025 in Review

Quantbot Technologies sold out of Cabaletta Bio (CABA) in Q1 2025, closing a stake of 19 shares — an estimated $43 sold.

Quantbot Technologies first reported a position in CABA in Q4 2023 and held it in 3 quarters. The position peaked at $34K in Q4 2023. 92 funds tracked by Wall St. Rank hold CABA as of Q1 2025.

  • Quantbot Technologies reported no remaining Cabaletta Bio position as of Q1 2025 after selling out during the quarter.
  • Quantbot Technologies sold 19 Cabaletta Bio shares in Q1 2025, an estimated $43.
  • Quantbot Technologies first reported a position in Cabaletta Bio in Q4 2023 and held it in 3 quarters.
  • Quantbot Technologies's Cabaletta Bio position peaked at $34K in Q4 2023.
  • 92 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2025.

Based on Quantbot Technologies's 13F filing for Q1 2025, filed 13 May 2025.